These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18843537)

  • 41. Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation.
    Reddy KR; Mutalik S; Reddy S
    AAPS PharmSciTech; 2003 Dec; 4(4):E61. PubMed ID: 15198556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
    Baviskar D; Sharma R; Jain D
    Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
    Quinten T; De Beer T; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hot-melt coating technology. I. Influence of Compritol 888 Ato and granule size on theophylline release.
    Faham A; Prinderre P; Farah N; Eichler KD; Kalantzis G; Joachim J
    Drug Dev Ind Pharm; 2000 Feb; 26(2):167-76. PubMed ID: 10697753
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dual release and molecular mechanism of bilayered aceclofenac tablet using polymer mixture.
    Van Nguyen H; Nguyen VH; Lee BJ
    Int J Pharm; 2016 Dec; 515(1-2):233-244. PubMed ID: 27744034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of beta-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets.
    Koester LS; Xavier CR; Mayorga P; Bassani VL
    Eur J Pharm Biopharm; 2003 Jan; 55(1):85-91. PubMed ID: 12551708
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Investigation on release model of insoluble drug in hydroxypropyl methycellulose matrix tablets].
    Ma XW; Yuan JQ; Liang WQ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 May; 33(3):225-8. PubMed ID: 15179683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Continuous twin screw granulation of controlled release formulations with various HPMC grades.
    Vanhoorne V; Janssens L; Vercruysse J; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2016 Sep; 511(2):1048-57. PubMed ID: 27521702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design and in vitro evaluation of zidovudine oral controlled release tablets prepared using hydroxypropyl methylcellulose.
    Ravi PR; Ganga S; Saha RN
    Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):518-24. PubMed ID: 18379101
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Poly vinyl acetate and ammonio methacrylate copolymer as unconventional polymer blends increase the mechanical robustness of HPMC matrix tablets.
    Ali R; Dashevsky A; Bodmeier R
    Int J Pharm; 2017 Jan; 516(1-2):3-8. PubMed ID: 27818241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and in vitro evaluation of multiparticulate sustained release carbamazepine formulation.
    Tomuţă I; Leucuţa SE
    Acta Pol Pharm; 2012; 69(5):951-64. PubMed ID: 23061293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigation of intrinsic dissolution behavior of different carbamazepine samples.
    Sehić S; Betz G; Hadzidedić S; El-Arini SK; Leuenberger H
    Int J Pharm; 2010 Feb; 386(1-2):77-90. PubMed ID: 19900519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of different excipients on the physical characteristics of granules and tablets with carbamazepine prepared with polyethylene glycol 6000 by fluidized hot-melt granulation (FHMG).
    Kraciuk R; Sznitowska M
    AAPS PharmSciTech; 2011 Dec; 12(4):1241-7. PubMed ID: 21948307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bioavailability of carbamazepine:beta-cyclodextrin complex in beagle dogs from hydroxypropylmethylcellulose matrix tablets.
    Koester LS; Bertuol JB; Groch KR; Xavier CR; Moellerke R; Mayorga P; Dalla Costa T; Bassani VL
    Eur J Pharm Sci; 2004 Jun; 22(2-3):201-7. PubMed ID: 15158905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimizing a wet granulation process to obtain high-dose sustained-release tablets with Compritol 888 ATO.
    Rosiaux Y; Girard JM; Desvignes F; Miolane C; Marchaud D
    Drug Dev Ind Pharm; 2015; 41(10):1738-44. PubMed ID: 25652358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
    Lee BJ; Ryu SG; Cui JH
    Int J Pharm; 1999 Oct; 188(1):71-80. PubMed ID: 10528084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets based on hydroxypropyl methylcellulose.
    Katzhendler I; Azoury R; Friedman M
    J Control Release; 1998 Jun; 54(1):69-85. PubMed ID: 9741905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Controlled release hydrophilic matrix tablet formulations of isoniazid: design and in vitro studies.
    Hiremath PS; Saha RN
    AAPS PharmSciTech; 2008; 9(4):1171-8. PubMed ID: 19015997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of HPMC - E15 LV premium polymer on release profile and compression characteristics of chitosan/ pectin colon targeted mesalamine matrix tablets and in vitro study on effect of pH impact on the drug release profile.
    Newton AM; Lakshmanan P
    Recent Pat Drug Deliv Formul; 2014 Apr; 8(1):46-62. PubMed ID: 24597626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.